wada bpc-157 prohibited list 2025 WADA's 2026 is now in force The 2025 WADA List of

One secondary endpoint in this trial was the comparison of glycemic parameters in the 3 groups by using continuous glucose monitoring (CGM) device worn for 10 days at baseline, week 20 and week 32 [10]

Exogenous testosterone at supratherapeutic doses suppresses HDL cholesterol and can adversely affect cardiovascular risk markers

Patients on Tirzepatide 15 mg weekly lost an average of 20.9% or 48.6 lb of their body weight after 72 weeks in the Zepbound Study 1 (NCT04184622) compared to placebo patients who lost an average of 3.1% or 7.2 lb

If your goal is direct mass gain, BPC-157 is not the tool for the job

Protect from light and moisture, keep sealed until reconstitution in a laboratory setting

2009, Nicolle et al